Psoriasis Drug Market

The Psoriasis Drug Market encompasses pharmaceutical products, particularly biologics and targeted therapies, for treating psoriasis. The primary customers are patients with the condition, who access these treatments through distribution channels like hospital and retail pharmacies. Market growth is propelled by the rising prevalence of psoriasis, greater awareness of advanced treatment options, and the increasing adoption of effective biologic drugs.